Skip to main content
. 2015 Feb 17;10(2):e0116886. doi: 10.1371/journal.pone.0116886

Table 4. Effect of HZ08 on reversing KB-WT cell and ABCB1-medicated MDR KB-VCR cells.

Compound KB-WT Cell KB-VCR Cell
IC50 (μM) FR IC50 (μM) FR
VCR 0.0015±0.0002 1.00 0.6187±0.1576 1.00
+10 μM VER 0.0008±0.0000** 1.83 0.0075±0.0015** 82.74
+10 μM HZ08 0.0004±0.0002** 3.67 0.0025±0.0010** 246.35
+5 μM HZ08 0.0009±0.0004 1.65 0.0036±0.0004** 173.46
+2.5 μM HZ08 0.0024±0.0021 0.64 0.0147±0.0097** 42.09
PTX 0.0037±0.0009 1.00 0.1935±0.0177 1.00
+10 μM VER 0.0018±0.0004* 2.03 0.0094±0.0010*** 20.60
+10 μM HZ08 0.0014±0.0004* 2.68 0.0015±0.0000*** 131.04
+5 μM HZ08 0.0019±0.0005* 1.97 0.0016±0.0007*** 120.06
+2.5 μM HZ08 0.0020±0.0004* 1.85 0.0184±0.0085** 10.50
DOX 0.0473±0.0197 1.00 0.2447±0.0398 1.00
+10 μM VER 0.0372±0.0171 1.27 0.0763±0.0068** 3.21
+10 μM HZ08 0.0399±0.0166 1.19 0.0512±0.0103** 4.78
+5 μM HZ08 0.0573±0.0264 0.83 0.0637±0.0166** 3.84
+2.5 μM HZ08 0.0461±0.0251 1.03 0.0757±0.0278** 3.23

Data are presented by mean±SD of three independent experiments performed in quadruple. Fold-resistance (FR) was calculated by dividing IC50 value for cells with chemotherapeutic drugs without HZ08 or VER by that obtained in the presence of these two drugs.

* P<0.05

** P<0.01

***P< 0.001 compared to the value obtained without HZ08 or VER.